ISSN 2149-2263 | E-ISSN 2149-2271 Home      
 
Volume : 24 Issue : 2
Current Issue Archive Popular Article Ahead of Print

 
Myocarditis associated with immune checkpoint inhibitors: Practical considerations in diagnosis and management [Anatol J Cardiol]
Anatol J Cardiol. 2020; 24(2): 68-75 | DOI: 10.14744/AnatolJCardiol.2020.79584  

Myocarditis associated with immune checkpoint inhibitors: Practical considerations in diagnosis and management

Muhammet Gürdoğan, Kenan Yalta
Department of Cardiology, Faculty of Medicine, Trakya University; Edirne-Turkey

Immune checkpoint inhibitors (ICI) have caused radical changes in the treatment scheme of many types of cancer in the past 10 years. ICIs are
specific monoclonal antibodies that increase T-cell mediated immune response against cancer cells. Despite important advances in cancer
treatment, uncontrolled activation of cytotoxic T cells has brought along many autoimmune clinical side effects, especially acute myocarditis.
Although the incidence of ICI-related myocarditis is about 1%, it is remarkable in terms of mortality rate reaching 46% and demonstrating the
necessity of rapid diagnosis and multidisciplinary approach. The present review aimed to summarize the heterogeneous symptomatology of
ICI-associated myocarditis, clinical presentation ranging from elevated asymptomatic cardiac enzyme levels to cardiogenic shock, prominent
diagnostic value of cardiac magnetic resonance imaging, and current information on the effectiveness of immunosuppressants in therapy.

Keywords: cardiotoxicity, immune checkpoint inhibitor, myocarditis


Muhammet Gürdoğan, Kenan Yalta. Myocarditis associated with immune checkpoint inhibitors: Practical considerations in diagnosis and management. Anatol J Cardiol. 2020; 24(2): 68-75

Corresponding Author: Muhammet Gürdoğan, Türkiye


TOOLS
Full Text PDF
Print
Download citation
RIS
EndNote
BibTex
Medlars
Procite
Reference Manager
Share with email
Share
Send email to author

Similar articles
PubMed
Google Scholar




 
 
KARE Publishing | Copyright © 2019 Turkish Society of Cardiology